Health experts warn that sitting with crossed legs for extended periods can increase the risk of deep vein thrombosis (DVT), ...

Dr. Nisha Bunke, the medical director at La Jolla Vein & Vascular, said she would never ignore skin discoloration and itching ...

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering ...

The use of JAK inhibitors in patients with AD are associated with greater risk for some thromboembolic outcomes compared with other treatments.

The female body is uniquely designed, and its differences like hormonal changes, pregnancy, and even smaller blood vessels, mean that these diseases can behave ...

A SURGERY fanatic has spent over £74,000 on a mission to look “perfect.” Lynn Harvey, who is known online as Linzee, used to ...

IPOH: Mercy Malaysia has officially donated medical equipment valued at RM340,200 to the Neurosurgical Critical Care Unit ...

For many Indians, flying has become almost routine, whether heading overseas for work, studying in another country, or simply ...

The leading causes of death in people with multiple myeloma include a weakened immune system, kidney failure, infections, and ...

Medically reviewed by Cara Beth Lee, MD There are many different causes of calf pain. It may be directly related to your calf ...

Donal Trump's mysterious bruise has led some to question whether it could be something more serious - with a vascular expert ...

Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura ® (ruxolitinib) cream 1.5%, a topical Janus kinase (JAK) inhibitor, for the short-term and ...